Feed / ILMN

Illumina, Inc.

ILMN

Healthcare · 198.25 -3.3% today

Follow ILMNAlerts

Jodie read · what matters now

Revenue slipped 0.7% to $4.3B in 2025 while operating margin swung back to 18.6%, a sharp profitability recovery alongside a flat top line.

The story is only the start. Jodie keeps watching the filing evidence, the companies connected to ILMN, and whether its market group begins moving.

P/E21.0xlatest annual facts
Revenue YoY-0.7%2025-12-28
Operating margin18.6%+37.6 pts YoY
Latest story10-K · Feb 12, 2026Read on Struct ↗
Disclosed connections22 verified links20 additional receipts in Pro
Organic co-movement groupLife Sciences Diagnostics · FollowerDiscovered from trading behaviour, not sector labels · Open group →

Who this business touches

The relationships behind ILMN

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

LABFiling-linked nameinvesteeFull receipt with Pro →

Depended on by

CDNACareDx, Inc.supplierFull receipt with Pro →

Filing peers

No filing peers are available for this name yet.

You can see the shape of the network here. Pro opens 20 more links, the original filing receipts, and alerts when connected names begin moving. See Pro →

What is moving around it

Live connections

ILMN is currently a Follower in the organic co-movement group Life Sciences Diagnostics. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

Theme membership history

No durable theme membership has been observed for this name yet.